Support Alert

Class 2 medicines recall: Bricanyl Injection 0.5 mg/ml solution for injection or infusion

AstraZeneca UK Limited has informed the Medicines and Healthcare products Regulatory Agency (MHRA) that it is recalling one batch of Bricanyl Injection 0.5 mg/ml solution for injection or infusion as a precautionary measure due to out of specification results for a routinely tested known impurity during stability testing.

Further information including the affected batch number, a brief description of the problem and advice for healthcare professionals can be found on the MHRA website.

Loading...

Renew for 2022

Your dedication to patient care has made us proud during 2021.

That's why you can count on us to represent your interests and support your efforts every step of the way in 2022.

RENEW YOUR MEMBERSHIP TODAY